Description
Biotech Co. Patents & Medical Device 5% Market Share = $90MM Revenue –
- Irvine, CA – (Orange County)
- Zip Code: 92614
- Asking Price: $4,000,000
- Cash Flow: N/A
- Gross Revenue: N/A
- EBITDA: N/A
- FF&E: N/A
- Inventory: N/A
- Established: N/A
Biotech Co. Patents & Medical Device For Sale –
(Business Description)
The Company has proprietary technology that addresses a leading cause
of maternal death (76,000) and fetal death (500,000) annually
worldwide.
8% of pregnancies in the US and 14% worldwide have diagnoses
that would be vastly improved by the worldwide commercialization of
the Company’s proprietary device.
A very low-risk procedure that both provides
quality of life improvement for the mother & baby and lowers health
care costs is a win/win/win for all involved!
Existing collaborations with major manufacturers coupled with a
current expedited approval process with the FDA presents a
tremendous opportunity for individuals or private equity groups
seeking a transformative investment into a feel-good biotech story
with exceptional legs and a vast runway with nearly unlimited upside.
Able to work with groups/individuals in tranches of $500k to $1MM to
advance into the pilot clinical study, $2-$3MM for the pivotal clinical study
towards market approval in the US.
They will seek direct sales with partnered hospitals, licensing / partnership deals could ultimately yield
the balance of funding to fully deploy a commercial version of the technology.
NDA is required for comprehensive Confidential Information Memorandum
(CIM) crafted by ProNova Partners.
Detailed Information –
(Biotech Co. Patents & Medical Device For Sale)
Competition: No current option available besides bed rest.
- No other commercialized drug/device therapies available, but several therapies under development.
- Non-specific columns may reduce sFlt-1 receptors among many other factors.
Growth & Expansion: Huge market potential!
- US market size is 300,000 preeclamptic women per year
- Adoption of 2% in first-year sales, then 5%, and 10%
- Treatment consists of 2 TAC-PEs/patient
- Estimated price of each TAC-PE column: $3,000
- The estimated manufacturing cost of each TAC-PE column: $1,000
- International market conservatively estimated as equivalent to the US, lagged 1 year
Support & Training: Full team included.
Reason for Selling: Seeking supportive capital partners to take to the next level(s).
ProNova Partners Buyer Profile & NDA
***RED STARS ARE REQUIRED FIELDS***
This information is required and must be filled in completely before the Seller will release any vital information, including business address, financial due diligence package on file, and other sensitive confidential information.
It will also be used by ProNova Partners to match your buyer profile with future similar engagements our firm has for sale.
* Required
function validateCaptcha()
{
var web_set_captcha = 'No';
web_set_captcha = document.getElementById('web_set_captcha').value;
if(web_set_captcha == 'Yes')
{
var googleResponse = $('#g-recaptcha-response').val();
if (!googleResponse) {
$('
Please Validate Captcha.
').insertAfter("#captcha_element");
return false;
} else
return true;
}
else
return true;
}